down arrow

IN8bio, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45674E1091
USD
1.82
0.04 (2.25%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.761.84

52 Week

1.5312.53
Valuation
Technical
Day's Volume

CASH

36.17 k

Shareholding (Mar 2025)

FII

5.09%

Held by 6 FIIs

DII

76.65%

Held by 6 DIIs

Promoter

11.86%

How big is IN8bio, Inc.?

22-Jun-2025

As of Jun 18, IN8bio, Inc. has a market capitalization of 7.37 million, with net sales of 0.00 million and a net profit of -27.43 million over the last four quarters. The company reported shareholder's funds of 14.48 million and total assets of 21.99 million as of Dec 24.

Market Cap: As of Jun 18, IN8bio, Inc. has a market capitalization of 7.37 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, IN8bio, Inc. reported net sales of 0.00 million and a net profit of -27.43 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 14.48 million and total assets of 21.99 million.

Read More

What does IN8bio, Inc. do?

22-Jun-2025

IN8bio, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $6 million and a market cap of $7.37 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -211.64%.

Overview: <BR>IN8bio, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -6 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 7.37 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.77 <BR>Return on Equity: -211.64% <BR>Price to Book: 0.53<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is IN8bio, Inc. technically bullish or bearish?

20-Sep-2025

As of August 14, 2025, IN8bio, Inc. shows a mildly bearish trend with mixed technical indicators, underperforming the S&P 500 by 73.3% year-to-date.

As of 14 August 2025, the technical trend for IN8bio, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI is bullish monthly but shows no signal weekly. However, the Bollinger Bands and moving averages indicate bearish conditions, particularly on the daily chart. Additionally, the KST and OBV are mildly bullish weekly but bearish monthly, and Dow Theory shows no trend weekly and mildly bearish monthly. <BR><BR>In terms of performance, IN8bio has significantly underperformed against the S&P 500 across all multi-period returns, with a year-to-date decline of 73.3% compared to the S&P's 12.22%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 10 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.81

stock-summary
Return on Equity

-192.72%

stock-summary
Price to Book

0.64

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.83%
0%
-17.83%
6 Months
-50.96%
0%
-50.96%
1 Year
-80.99%
0%
-80.99%
2 Years
-92.82%
0%
-92.82%
3 Years
-14.15%
0%
-14.15%
4 Years
-98.92%
0%
-98.92%
5 Years
0%
0%
0.0%

IN8bio, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is IN8bio, Inc. technically bullish or bearish?

As of 14 August 2025, the technical trend for IN8bio, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI is bullish monthly but shows no signal weekly. However, the Bollinger Bands and moving averages indicate bearish conditions, particularly on the daily chart. Additionally, the KST and OBV are mildly bullish weekly but bearish monthly, and Dow Theory shows no trend weekly and mildly bearish monthly. In terms of performance, IN8bio has significantly underperformed against the S&P 500 across all multi-period returns, with a year-to-date decline of 73.3% compared to the S&P's 12.22%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
2.44%
EBIT to Interest (avg)
-29.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
33.06%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.03
EV to EBIT
-0.13
EV to EBITDA
-0.14
EV to Capital Employed
1.15
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-917.51%
ROE (Latest)
-211.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 7 Schemes (6.39%)

Foreign Institutions

Held by 6 Foreign Institutions (5.09%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 40.70% vs -11.69% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.70",
          "val2": "-8.10",
          "chgp": "41.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.10",
          "val2": "-8.60",
          "chgp": "40.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.33% vs -5.26% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-26.90",
          "val2": "-27.80",
          "chgp": "3.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-30.40",
          "val2": "-30.00",
          "chgp": "-1.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-4.70
-8.10
41.98%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.10
-8.60
40.70%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 40.70% vs -11.69% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-26.90
-27.80
3.24%
Interest
0.00
0.00
Exceptional Items
-1.10
0.00
Consolidate Net Profit
-30.40
-30.00
-1.33%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -1.33% vs -5.26% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About IN8bio, Inc. stock-summary
stock-summary
IN8bio, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."